AssetMark’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
AssetMark's PVLA Position: Q3 2026 in Review
AssetMark opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 1 share worth $138. The stake represents ﹤0.01% of the portfolio and ranks #3664 among its holdings.
141 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- AssetMark held 1 share of Palvella Therapeutics worth $138 as of Q3 2026.
- Palvella Therapeutics was a new AssetMark position in Q3 2026.
- Palvella Therapeutics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3664 holding.
- 141 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.